{
  "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
  "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
  "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
  "authorId": "neumora-therapeutics",
  "authorName": "Neumora Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 3,
  "pageCount": 32,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "appendix_data",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/3",
  "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
  "deckJsonHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507.json",
  "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.96,
        "x": 0.02,
        "y": 0.18
      },
      "kind": "table",
      "text": "Issuer (Exchange / Ticker): Neumora Therapeutics, Inc. (Nasdaq / NMRA)\nBase offering size: 14,710,000 shares (100% primary)\nOption to purchase additional shares: 2,206,500 shares (15% of base deal, 100% primary)\nPrice range: $16.00 - $18.00 per share\nUse of proceeds: Neumora Therapeutics anticipates to use the net proceeds of this offering, together with its existing cash, cash equivalents and marketable securities, as follows: approximately $395 million to fund the clinical and preclinical development of our current programs; approximately $30 million to fund research and development activities for additional programs; and the remainder for working capital and other general corporate purposes.\nBookrunners: J.P. Morgan, BofA Securities, Stifel, Guggenheim Securities, RBC Capital Markets, William Blair\nStabilization agent: J.P. Morgan\nExpected pricing date: As early as Thursday, September 14th, 2023\nLock-up: 180 days for the Company, directors, officers, affiliates and substantially all security holders",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd5ecea3-a57e-46a8-b914-9fd52dadeec8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.25,
        "x": 0.02,
        "y": 0.04
      },
      "kind": "title",
      "text": "Offering summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d69b08c-0c24-41f9-9a3f-99459d4a9f71",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 1,
      "beatId": "3bd59596-460d-4a33-994d-5327f8bc4717",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Setup",
      "beatSlug": "setup",
      "evidence": "The cover, mission, executive summary, and team bio slides provide an introduction to the company and its goals.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}